Saturday, 27 November 2021

TataMD, Anderson Diagnostics collaborate to scale-up COVID-19 kit production

22 March 2021 | News

The partnership will act as an enabler to optimise the delivery of the COVID tests and help slow down the rate of infections

Source credit: Shutterstock

Source credit: Shutterstock

Tata Medical and Diagnostics (TataMD) has announced that it has entered into a wide-ranging clinical collaboration with Chennai-based Anderson Diagnostics & Labs (ADL), to standardise the indigenously - developed TataMD CHECK in a bid to slow down the rate of new infections. 

The collaboration with clinical experts of ADL has helped ensure that the ‘Made-in-India’ TataMD CHECK diagnostic kit can be scaled rapidly with ADL having already successfully conducted over 10,000 COVID tests using this new, DGCA approved ICMR guidelines, novel diagnostic solution based on Feluda CRISPR Platform.

“Our clinical partnership with Tata MD will help support the transformation of COVID testing to arrest the emergence of a second wave in India and around the world,” said Dr Srinivasaraman, Director, Anderson Diagnostics and Labs.

TataMD CHECK’s ability to perform using inexpensive lab equipment like standard thermocyclers will be a boost for small labs in tier II/III towns and villages to start COVID testing locally,” said Dr Anand Krishnamoorthy, Managing Director, Anderson Diagnostics.

“Working with the exceptional team at Anderson Diagnostics has demonstrated the impact that a new technology-based product like TataMD CHECK can have on strengthening our COVID testing capacity and access to testing in remote areas. Tata’s clinical collaboration with Anderson Diagnostics will only drive advances in the diagnostic space of COVID-19 as the pandemic continues,” said Girish Krishnamurthy, MD & CEO, Tata Medical and Diagnostics.

Strong strategic partnerships allow each partner to bring in their strengths, creating a synergy that augments the efforts in the battle against COVID. The partnership between Tata MD and Anderson Diagnostics and Labs will act as an enabler to optimise the delivery of the COVID tests, advance diagnosis for emerging pandemic and diseases, create more value for the people and allow easier access to the tests. Together with its partners, TataMD will drive change in healthcare through the latest technology and provide COVID-19 testing wherever and whenever needed.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

//Survey Form JS Starts //Survey Form JS Ends